Search results

309 items matching your search terms.
Filter the results.
Item type













New items since



Sort by relevance · date (newest first) · alphabetically
Study quantifies false positives for yearly mammograms
Breast Cancer Surveillance Consortium also compares digital and film mammography
Located in News / 2011 News
Meet a Tar Heel: Giselle Corbie-Smith
Located in News / 2011 News
UNC nanotech entrepreneur to speak at TEDMED annual conference
Joseph DeSimone, PhD, has been invited to join an elite list of speakers at this year’s TEDMED Conference in San Diego, Calif., Oct. 25 – 28.
Located in News / 2011 News
Meet Kimryn Rathmell, MD, PhD - a kidney cancer doctor at UNC Lineberger
Kimryn Rathmell, MD, PhD, thrives on discovery, whether in her lab developing a new experiment for kidney cancer or in her kitchen trying out a new food or cuisine.
Located in News / 2011 News
Allbritton talks about studying cells
Located in News / 2011 News
Study confirms males and females have at least one thing in common: upregulating X
Cellular “mathematics” help equalize X chromosome gene expression
Located in News / 2011 News
UNC cancer researcher awarded top V Scholar ranking
The V Foundation for Cancer Research announced this week that Greg Wang, PhD, has been awarded the Martin D. Abeloff, MD, V Scholar Award. This award goes to the research project that receives the highest rating from the V Foundation’s Scientific Advisory Board. Wang was tied with Hongwu Zheng, PhD, of Cold Spring Harbor Laboratory for this honor and is the 10th V Scholar from UNC Lineberger.
Located in News / 2011 News
Multidisciplinary research urged for optimal melanoma surgery
UNC surgical oncologist co-authors Lancet editorial
Located in News / 2011 News
UNC scientist receives grant to identify biomarkers for breast cancer recurrence risk
Chapel Hill - A UNC scientist was awarded one of seven grants presented by the Avon Walk for Breast Cancer at their seventh annual event in Charlotte, NC.
Located in News / 2011 News
UNC scientists offer first evidence of using biologically targeted nanoparticles to boost radiation therapy effects
Chapel Hill - Making a tumor more sensitive to radiotherapy is a primary goal of combining chemo and radiation therapy to treat many types of cancer, but with the chemotherapy drugs come unwanted side effects.
Located in News / 2011 News